Concepedia

Xiaoying Lan

XL

Statistics

Publications

15

Citations

945

H-Index

15

Active since

2013

Affiliations

Guangzhou Medical University(Current)

University of South Dakota

Second Affiliated Hospital of Guangzhou Medical University

The Barbara Ann Karmanos Cancer Institute

Wayne State University

Xiaoying Lan is an author at Guangzhou Medical University specializing in molecular oncology, medicine, and proteasome inhibitors.

Publications per year

2013–2019

15

Publications

15

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

Ningning Liu, Xiaofen Li, Hongbiao Huang et al. · Oncotarget · 2014 · 171 citations · Full text

, , +8

Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation

Xianping Shi, Xin Chen, Xiaofen Li et al. · Clinical Cancer Research · 2013 · 129 citations · Full text

, , +14

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer

Lu Xiao, Xiaoying Lan, Xianping Shi et al. · Cell Death and Disease · 2017 · 97 citations · Full text

, , +16

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

Xin Chen, Xianping Shi, Chong Zhao et al. · Oncotarget · 2014 · 81 citations · Full text

, , +14

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases

Ningning Liu, Chunjiao Liu, Xiaofen Li et al. · Scientific Reports · 2014 · 76 citations · Full text

, , +13

1–5 of 15